EPCAM and breast carcinoma: Our data supports previous data on breast cancer showing that the expression of PD-L1 was strongly associated with stem cell-like cells where the CSC population (EpCAM+CD44hiCD24lo) had a higher level of PD-L1 compared to their counterparts (EpCAMlo/negCD44loCD24hi) [34,35].